This Small-Cap Cancer Technology Company Could Pop With the Right Play

Let's look at a strategy for Cardiff Oncology, whose shares got snagged in the biotech selloff in early 2022....CRDF

Related Keywords

,Pfizer ,Cardiff Oncology ,Polo Like Kinase ,Financial ,News ,Stock ,Market ,Headlines ,Investments ,Uotes ,Trading ,Hestreet ,Ret Jensen ,Investing ,Acrdf ,